213 related articles for article (PubMed ID: 26907715)
1. Non-focal liver signal abnormalities on hepatobiliary phase of gadoxetate disodium-enhanced MR imaging: a review and differential diagnosis.
Furlan A; Borhani AA; Heller MT; Yu RK; Tublin ME
Abdom Radiol (NY); 2016 Jul; 41(7):1399-410. PubMed ID: 26907715
[TBL] [Abstract][Full Text] [Related]
2. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
3. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
Gupta RT; Marin D; Boll DT; Husarik DB; Davis DE; Feuerlein S; Merkle EM
Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hepatocellular carcinoma conspicuity on hepatobiliary phase images with gadoxetate disodium vs. delayed phase images with extracellular cellular contrast agent.
Kim SY; Wu EH; Park SH; Wang ZJ; Hope TA; Yee J; Zhao LQ; Chang WC; Yeh BM
Abdom Radiol (NY); 2016 Aug; 41(8):1522-31. PubMed ID: 26971341
[TBL] [Abstract][Full Text] [Related]
5. Hepatic steatosis: effect on hepatocyte enhancement with gadoxetate disodium-enhanced liver MR imaging.
Onishi H; Theisen D; Dietrich O; Reiser MF; Zech CJ
J Magn Reson Imaging; 2014 Jan; 39(1):42-50. PubMed ID: 24339365
[TBL] [Abstract][Full Text] [Related]
6. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
7. Imaging findings of primary hepatic angiosarcoma on gadoxetate disodium-enhanced liver MRI: comparison with hepatic haemangiomas of similar size.
Kim B; Byun JH; Lee JH; Park BJ; Kwon HJ; Lee JH; Lee SJ; Won HJ; Shin YM; Kim PN
Clin Radiol; 2018 Mar; 73(3):244-253. PubMed ID: 29111237
[TBL] [Abstract][Full Text] [Related]
8. Distinguishing hemangiomas from metastases on liver MRI performed with gadoxetate disodium: Value of the extended washout sign.
Agarwal S; Grajo JR; Fuentes-Orrego JM; Abtahi SM; Harisinghani MG; Saini S; Hahn PF
Eur J Radiol; 2016 Mar; 85(3):635-40. PubMed ID: 26860678
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
10. Optimal Combination of Features on Gadoxetate Disodium-enhanced MR Imaging for Non-invasive Differential Diagnosis of Hepatocellular Carcinoma: The JAMP-HCC Study.
Ichikawa S; Motosugi U; Morisaka H; Kozaka K; Goshima S; Ichikawa T
Magn Reson Med Sci; 2021 Mar; 20(1):47-59. PubMed ID: 32101818
[TBL] [Abstract][Full Text] [Related]
11. Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.
Taibbi A; Brancatelli G; Matranga D; Midiri M; Lagalla R; Bartolotta TV
Diagn Interv Radiol; 2019 Mar; 25(2):95-101. PubMed ID: 30860073
[TBL] [Abstract][Full Text] [Related]
12. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
Kim MJ; Rhee HJ; Jeong HT
AJR Am J Roentgenol; 2012 Nov; 199(5):W575-86. PubMed ID: 23096201
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
[TBL] [Abstract][Full Text] [Related]
14. Is there an added value of a hepatobiliary phase with gadoxetate disodium following conventional MRI with an extracellular gadolinium agent in a single imaging session for detection of primary hepatic malignancies?
Pahade JK; Juice D; Staib L; Israel G; Cornfeld D; Mitchell K; Weinreb J
Abdom Radiol (NY); 2016 Jul; 41(7):1270-84. PubMed ID: 26800701
[TBL] [Abstract][Full Text] [Related]
15. Evolution of hypointense hepatocellular nodules observed only in the hepatobiliary phase of gadoxetate disodium-enhanced MRI.
Kumada T; Toyoda H; Tada T; Sone Y; Fujimori M; Ogawa S; Ishikawa T
AJR Am J Roentgenol; 2011 Jul; 197(1):58-63. PubMed ID: 21701011
[TBL] [Abstract][Full Text] [Related]
16. Focal liver lesion detection and characterization with GD-EOB-DTPA.
Purysko AS; Remer EM; Veniero JC
Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
[TBL] [Abstract][Full Text] [Related]
18. Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver.
Huh J; Kim SY; Yeh BM; Lee SS; Kim KW; Wu EH; Wang ZJ; Zhao LQ; Chang WC
Korean J Radiol; 2015; 16(6):1207-15. PubMed ID: 26576109
[TBL] [Abstract][Full Text] [Related]
19. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
20. Liver perfusion in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI): comparison of enhancement in Gd-BT-DO3A and Gd-EOB-DTPA in normal liver parenchyma.
Schalkx HJ; van Stralen M; Coenegrachts K; van den Bosch MA; van Kessel CS; van Hillegersberg R; van Erpecum KJ; Verkooijen HM; Pluim JP; Veldhuis WB; van Leeuwen MS
Eur Radiol; 2014 Sep; 24(9):2146-56. PubMed ID: 24996795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
